Madeline Mayday, BS, a fourth-year Experimental Pathology graduate student in the Laboratory of Diane Krause, MD, PhD, was recently awarded a 2022 National Institute of Diabetes and Digestive and Kidney Diseases Hematology Centers Program Type B Pilot and Feasibility grant for her project entitled, “Investigation of RBM15 and the m6A Epitranscriptome in Megakaryopoiesis.”
The NIDDK is an institute within the National Institutes of Health. The NIDDK Hematology Centers Program provides a novel support mechanism for researchers to pursue new directions in benign hematology. The grants are designed to support innovative pilot research projects in benign hematology, including the generation of preliminary data for larger research grants.
Madeline is a PhD candidate in the Department of Pathology and is part of the Medical Research Scholars Program. She is originally from Muskoka, Ontario, and graduated with a BS in Cell and Molecular Biology from San Francisco State University. She then worked as a Research Associate at UCSF to develop a protocol for detection of pathogens causing respiratory failure in pediatric HSC transplant patients.
Madeline began her graduate studies in the Translational Molecular Medicine, Pharmacology and Physiology (TMMPP) program at Yale in Fall 2019 and joined the Krause Lab in May 2022 with an interest in translational research and hematopoiesis.